Nektar Therapeutics

Huntsville, AL 35801

Market Performance

NASDAQ: NKTR
Market Cap $3.77 Billion
52 Week High $25.02
52 Week Low $11.41

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $99.2K
First Award Date 05/01/98
Most Recent Award Date 01/16/03

Key Personnel

Last Name Name Awards Contact
Harris J Milton Harris 1
Ghandehari Hamid Ghandehari 2

3 Awards Won

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 01/16/03 - 06/30/04

DESCRIPTION (provided by applicant): A clinically promising prodrug for cancer chemotherapy is irinotecan or 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11)which is converted to the active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) in the presence of carboxylesterases (CE). SN-38 inhibits topoisomerase I, causes...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/02 - 01/15/03

DESCRIPTION (provided by applicant): A clinically promising prodrug for cancer chemotherapy is irinotecan or 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11)which is converted to the active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) in the presence of carboxylesterases (CE). SN-38 inhibits topoisomerase I, causes...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/98 - 10/31/98

An urgent need exists for new and more effective antimalarials. Preliminary studies indicate that when the Chinese traditional medicinal drug, artemisinin, is covalently bonded through an ester linkage to poly(ethylene glycol) (PEG), the resulting molecule has much higher antimalarial activity t...